Fine-tuning anti-tumor immunotherapies via stochastic simulations

BACKGROUND: Anti-tumor therapies aim at reducing to zero the number of tumor cells in a host within their end or, at least, aim at leaving the patient with a sufficiently small number of tumor cells so that the residual tumor can be eradicated by the immune system. Besides severe side-effects, a key...

Descripción completa

Detalles Bibliográficos
Autores principales: Caravagna, Giulio, Barbuti, Roberto, d'Onofrio, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303725/
https://www.ncbi.nlm.nih.gov/pubmed/22536975
http://dx.doi.org/10.1186/1471-2105-13-S4-S8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303725/
https://www.ncbi.nlm.nih.gov/pubmed/22536975
http://dx.doi.org/10.1186/1471-2105-13-S4-S8

Ejemplares similares